BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22328174)

  • 1. Utility of a column-free cell sorting system for separation of plasma cells in multiple myeloma FISH testing in clinical laboratories.
    Shetty S; Siady M; Mallempati KC; Wilson A; Poarch J; Chandler B; Gray J; Salama ME
    Int J Hematol; 2012 Mar; 95(3):274-81. PubMed ID: 22328174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of immunomagnetic sorting on detecting genetic aberration of multiple myeloma cells by interphase fluorescence in situ hybridization].
    An G; Li CW; Li Q; Yi SH; Liu XP; Xu Y; Li ZJ; Qi JY; Zou DH; Qiu LG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):54-8. PubMed ID: 21362221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified cIg-FISH protocol for multiple myeloma in routine cytogenetic laboratory practice.
    Gole L; Lin A; Chua C; Chng WJ
    Cancer Genet; 2014; 207(1-2):31-4. PubMed ID: 24485403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of CD138 Immunomagnetic Sorting Myeloma Cells Combined with Fluorescence in Situ Hybridization for Detecting Cytogenetic Abnormalities of Multiple Myeloma].
    Gao L; Liu Q; Shi Y; Dang H; He Q; Wang Z; Feng L; Li Y; Wang XY; Li N; Song WJ; Wang YL; Kong S; Lu J; Huang XJ; Lai YY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):807-812. PubMed ID: 28641640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of CD138 Immunomagnetic Bead Sorting Combined with Fluorescence in Situ Hybridization in Multiple Myeloma].
    Li QZ; Tan K; Liu YX; Huang H; Zhang Y; Chen HM; Chen ZZ; Zhu ZW; Yang BH; Hu GY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1496-1500. PubMed ID: 36208255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of an immune-magnetic cell sorting method for CD138-positive plasma cells in FISH analysis of multiple myeloma.
    Shin SY; Jang S; Park CJ; Chi HS; Lee JH; Lee JH; Lee KH; Suh C; Lim SE; Seo EJ
    Int J Lab Hematol; 2012 Oct; 34(5):541-6. PubMed ID: 22672327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk stratification of plasma cell neoplasm: insights from plasma cell-specific cytoplasmic immunoglobulin fluorescence in situ hybridization (cIg FISH) vs. conventional FISH.
    Dong H; Yang HS; Jagannath S; Stephenson CF; Brenholz P; Mazumder A; Chari A
    Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):366-74. PubMed ID: 22658896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superior detection rate of plasma cell FISH using FACS-FISH.
    Gagnon MF; Midthun SM; Fangel JA; Schuh CM; Luoma IM; Pearce KE; Meyer RG; Ailawadhi S; Arribas MJ; Braggio E; Fonseca R; Rajkumar SV; Zepeda-Mendoza C; Xu X; Greipp PT; Timm MM; Otteson GE; Shi M; Jevremovic D; Olteanu H; Peterson JF; Ketterling RP; Kumar S; Baughn LB
    Am J Clin Pathol; 2024 Jan; 161(1):60-70. PubMed ID: 37658775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of Molecular Cytogenetic Aberrations by Fluorescence in Situ Hybridization in Different Bone Marrow Samples of Multiple Myeloma].
    Wang YF; Wang H; Xi LY; Liu Y; Dong F; Wang JJ; Ke XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1352-6. PubMed ID: 26524036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic testing by fluorescence in situ hybridization is improved by plasma cell sorting in multiple myeloma.
    Ha J; Cho H; Lee TG; Shin S; Chung H; Jang JE; Kim SJ; Cheong JW; Lee ST; Kim JS; Choi JR
    Sci Rep; 2022 May; 12(1):8287. PubMed ID: 35585097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application Value of CD138 MACS-FISH in the Genetic Diagnosis of Plasma Cell Dyscrasia].
    Mei JG; Li HQ; Cao HQ; Shao JJ; Zhai YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1437-1442. PubMed ID: 27784371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma cell enrichment enhances detection of high-risk cytogenomic abnormalities by fluorescence in situ hybridization and improves risk stratification of patients with plasma cell neoplasms.
    Lu G; Muddasani R; Orlowski RZ; Abruzzo LV; Qazilbash MH; You MJ; Wang Y; Zhao M; Chen S; Glitza IC; Medeiros LJ
    Arch Pathol Lab Med; 2013 May; 137(5):625-31. PubMed ID: 23627452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of genomic abnormalities in multiple myeloma: the application of FISH analysis in combination with various plasma cell enrichment techniques.
    Hartmann L; Biggerstaff JS; Chapman DB; Scott JM; Johnson KR; Ghirardelli KM; Fritschle WK; Martinez DL; Bennington RK; de Baca ME; Wells DA; Loken MR; Zehentner BK
    Am J Clin Pathol; 2011 Nov; 136(5):712-20. PubMed ID: 22031309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
    Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
    Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of laboratory methods for the detection of neoplastic plasma cells in plasma cell dyscrasias.
    Dietz R; Lollie TK; Goh T; Rao N; Pullarkat S
    J Clin Pathol; 2022 Nov; 75(11):739-743. PubMed ID: 36257676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of cytomorphology, immunophenotyping, and interphase fluorescence in situ hybridization in 381 patients with monoclonal gammopathy of undetermined significance and 301 patients with plasma cell myeloma.
    Bacher U; Haferlach T; Kern W; Alpermann T; Schnittger S; Haferlach C
    Cancer Genet Cytogenet; 2010 Dec; 203(2):169-75. PubMed ID: 21156229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype/genotype fluorescence in situ hybridization.
    Slovak ML; Bedell V; Pagel K; Chang KL; Smith D; Somlo G
    Cancer Genet Cytogenet; 2005 Apr; 158(2):99-109. PubMed ID: 15796956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High detection rate of clinically relevant genomic abnormalities in plasma cells enriched from patients with multiple myeloma.
    Stevens-Kroef M; Weghuis DO; Croockewit S; Derksen L; Hooijer J; Elidrissi-Zaynoun N; Siepman A; Simons A; Kessel AG
    Genes Chromosomes Cancer; 2012 Nov; 51(11):997-1006. PubMed ID: 22833442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Magnetic-activated cell sorting combined with multiplex ligation-dependent probe amplification for detecting molecular cytogenetic abnormalities in multiple myeloma].
    Lei M; Ma L; Kuang L; Pang Y; Wu J; Xiao Z; Li L
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Sep; 32(9):1332-5. PubMed ID: 22985577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of bone marrow plasma cell infiltration in multiple myeloma: usefulness of bone marrow aspirate clot with CD138 immunohistochemistry.
    Matsue K; Matsue Y; Kumata K; Usui Y; Suehara Y; Fukumoto K; Fujisawa M; Narita K; Takeuchi M
    Hematol Oncol; 2017 Sep; 35(3):323-328. PubMed ID: 27140172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.